AnalystsColleen Kusy
Colleen Kusy's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4710 out of 4929 analysts
Average Return
-17.57%
Win Rate
29%13 out of 45
Risk vs Reward
Poor
Good

Colleen Kusy's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iveric Bio IncISEE
+150.13%$14.94$37.37
2022-09-06 -
2023-05-04
Buy
Ocular Therapeutix IncOCUL
+149.31%$3.61$9.00
2023-09-13 -
2024-09-13
Buy
Surface Oncology IncSURF
+85.12%$0.58$1.07
2023-05-03 -
2023-09-07
Buy
Oculis Holding AgOCS
+66.02%$11.92$19.79
2024-06-10 -
2025-06-10
Buy
Apellis Pharmaceuticals IncAPLS
+63.50%$24.22$39.60
2023-07-31 -
2024-07-31
Buy

Colleen Kusy Analyst Color

Get additional color on Colleen Kusy's coverage of popular stocks

Colleen Kusy's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nuvalent IncNUVL
2Buy$112.00+39.17%Maintains
9 days ago
Enliven Therapeutics IncELVN
3Buy$52.00+150.84%Maintains
18 days ago
Agenus IncAGEN
4Hold$6.00-1.15%Maintains
a month ago
Apellis Pharmaceuticals IncAPLS
11Buy$47.00+157.39%Maintains
2 months ago
Oculis Holding AgOCS
4Buy$41.00+115.79%Maintains
4 months ago
Coherus Biosciences IncCHRS
5Buy$6.00+640.74%Maintains
7 months ago
Spyre Therapeutics IncSYRE
2Buy$65.00+312.44%Maintains
8 months ago
Mersana Therapeutics IncMRSN
4Hold$3.00+938.06%Maintains
a year ago
Ocular Therapeutix IncOCUL
4Buy$17.00+76.72%Maintains
a year ago
Oric Pharmaceuticals IncORIC
1Buy$25.00N/AReiterates
a year ago
Surface Oncology IncSURF
5Buy$6.00N/AMaintains
2 years ago
Iveric Bio IncISEE
3Hold$40.00N/ADowngrades
2 years ago
Harpoon Therapeutics IncHARP
1HoldN/AN/ADowngrades
3 years ago
Aveo Pharmaceuticals IncAVEO
1Hold$15.00N/ADowngrades
3 years ago
Karyopharm Therapeutics IncKPTI
1Buy$210.00N/AMaintains
3 years ago
Iovance Biotherapeutics IncIOVA
2Buy$34.00N/AMaintains
3 years ago
Sab Biotherapeutics IncSABS
1Buy$230.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.